Finance

Lists
NATCOPHARM:NSE
Natco Pharma
₹819,00
-1,03%
(-8,50) 1D
1 Okt., 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NATCOPHARM...
Open
₹814,95
High
₹827,10
Low
₹804,00
Mkt. cap
147,25 mjd
Avg. vol.
420,64 k
Volume
717,44 k
Dividend
0,55%
Quarterly dividend
₹1,13
Ex-dividend date
20 Aug. 2026
P/E ratio
12,82
52-wk high
₹1 226,80
52-wk low
₹792,05
EPS
₹63,89
Shares outstanding
182,26 m
No. of employees
4 k
Open
₹814,95
High
₹827,10
Low
₹804,00
Mkt. cap
147,25 mjd
Avg. vol.
420,64 k
Volume
717,44 k
Dividend
0,55%
Quarterly dividend
₹1,13
Ex-dividend date
20 Aug. 2026
P/E ratio
12,82
52-wk high
₹1 226,80
52-wk low
₹792,05
EPS
₹63,89
Shares outstanding
182,26 m
No. of employees
4 k
News stories
From web sources and news partners
Profile
Natco Pharma Ltd is 'n Indiese farmaseutiese maatskappy wat aktiewe farmaseutiese bestanddele asook klaar produkte vervaardig. Wikipedia
About Natco Pharma
CEORajeev Nannapaneni
Employees4,43 k
Founded1981
HeadquartersBanjara Hills, Telangana, Indië
SectorPharmaceutical industry
Last report
14 Aug. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹11,53 / ₹8,86
+30,06%beat
Revenue / Est. (INR)
7,35 mjd / 7,96 mjd
-7,66%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
13,63 mjd
6,47 mjd
7,43 mjd
7,35 mjd
Cost of goods sold
1,70 mjd
1,33 mjd
1,99 mjd
1,48 mjd
Cost of revenue
1,70 mjd
1,33 mjd
1,99 mjd
1,48 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,00 mjd
1,59 mjd
1,63 mjd
1,79 mjd
Operating expense
6,66 mjd
4,02 mjd
4,38 mjd
4,48 mjd
Total operating expenses
8,36 mjd
5,35 mjd
6,37 mjd
5,96 mjd
Operating income
5,27 mjd
1,12 mjd
1,06 mjd
1,39 mjd
Other non operating income
1,00 mjd
581,00 m
-2,11 mjd
592,00 m
EBT including unusual items
6,14 mjd
1,72 mjd
1,80 mjd
2,70 mjd
EBT excluding unusual items
6,14 mjd
1,72 mjd
2,02 mjd
2,70 mjd
Income tax expense
958,00 m
207,00 m
-892,00 m
634,00 m
Effective tax rate
15,61%
12,03%
-49,61%
23,49%
Other operating expenses
4,14 mjd
1,96 mjd
2,23 mjd
2,22 mjd
Net income
5,18 mjd
1,52 mjd
2,68 mjd
2,06 mjd
Net profit margin
38,03%
23,40%
36,08%
28,09%
Earnings per share
28,94
8,46
14,96
11,53
Interest and investment income
-
-
2,33 mjd
-
Interest expense
-131,00 m
-95,00 m
-
-130,00 m
Net interest expenses
-131,00 m
-95,00 m
2,33 mjd
-130,00 m
Depreciation and amortization charges
524,00 m
462,00 m
504,00 m
471,00 m
EBITDA
5,82 mjd
1,57 mjd
1,55 mjd
1,91 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme